InChI=1S/C18H16O8/c1-23-12-7-11-13(14(21)17(12)24-2)15(22)18(25-3)16(26-11)8-4-5-9(19)10(20)6-8/h4-7,19-21H,1-3H3 |
BYWLLSQTJBXAPV-UHFFFAOYSA-N |
COc1cc2oc(-c3ccc(O)c(O)c3)c(OC)c(=O)c2c(O)c1OC |
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
Outgoing
|
3',4',5-trihydroxy-3,6,7-trimethoxyflavone
(CHEBI:18016)
has functional parent
quercetagetin
(CHEBI:8695)
3',4',5-trihydroxy-3,6,7-trimethoxyflavone
(CHEBI:18016)
has role
antineoplastic agent
(CHEBI:35610)
3',4',5-trihydroxy-3,6,7-trimethoxyflavone
(CHEBI:18016)
has role
metabolite
(CHEBI:25212)
3',4',5-trihydroxy-3,6,7-trimethoxyflavone
(CHEBI:18016)
is a
trihydroxyflavone
(CHEBI:27116)
3',4',5-trihydroxy-3,6,7-trimethoxyflavone
(CHEBI:18016)
is a
trimethoxyflavone
(CHEBI:27124)
|
|
2-(3,4-dihydroxyphenyl)-5-hydroxy-3,6,7-trimethoxy-4H-chromen-4-one
|
3',4',5-Trihydroxy-3,6,7-trimethoxyflavone
|
KEGG COMPOUND
|
3',4',5-trihydroxy-3,6,7-trimethoxyflavone
|
UniProt
|
Chrysosplenol D
|
KEGG COMPOUND
|
quercetagetin 3,6,7-trimethyl ether
|
ChEBI
|
350587
|
Reaxys Registry Number
|
Reaxys
|
11141110
|
PubMed citation
|
Europe PMC
|
18855445
|
PubMed citation
|
Europe PMC
|
21469236
|
PubMed citation
|
Europe PMC
|
|